Akero Therapeutics, Inc.
AKRO
$37.63
$0.190.51%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 3.60% | -5.65% | -15.88% | 64.30% | -0.85% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -7.89% | 87.41% | 107.70% | -23.48% | -53.16% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 3.15% | -3.75% | -14.84% | 62.74% | -2.78% |
|
|||||
Total Current Assets | 3.15% | -3.75% | -14.84% | 62.74% | -2.78% |
Net Property, Plant & Equipment | -9.58% | -7.22% | -6.54% | -6.14% | -5.70% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 1.02% | -5.49% | -5.17% | 57.21% | -8.67% |
|
|||||
Total Accounts Payable | -64.21% | 73.14% | 5.70% | 95.84% | -38.55% |
Total Accrued Expenses | 72.60% | 9.14% | 0.89% | 36.89% | -19.73% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.83% | 2.91% | 3.00% | -48.85% | 107.14% |
Total Finance Division Other Current Liabilities | -2.30% | -1.69% | -5.09% | -- | -- |
Total Other Current Liabilities | -2.30% | -1.69% | -5.09% | -- | -- |
Total Current Liabilities | -8.17% | 38.87% | 3.02% | 58.19% | -32.76% |
|
|||||
Total Current Liabilities | -8.17% | 38.87% | 3.02% | 58.19% | -32.76% |
Long-Term Debt | 0.50% | 0.47% | 0.45% | 39.41% | 9.65% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -12.56% | -10.90% | -9.47% | -8.42% | -7.77% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -4.43% | 23.78% | -7.87% | 229.63% | -41.94% |
Total Liabilities | -4.35% | 18.28% | 1.49% | 46.76% | -13.85% |
|
|||||
Common Stock & APIC | 5.56% | 0.72% | 0.54% | 32.88% | 0.60% |
Retained Earnings | -9.26% | -10.64% | -8.92% | -9.29% | -10.63% |
Treasury Stock & Other | -54.92% | 905.75% | -230.38% | -129.26% | 153.36% |
Total Common Equity | 1.60% | -7.49% | -5.69% | 58.09% | -8.20% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 1.60% | -7.49% | -5.69% | 58.09% | -8.20% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 1.60% | -7.49% | -5.69% | 58.09% | -8.20% |
|